DEC 19, 2020 11:15 AM PST

Urine Tests Sets Parents' Minds at Ease in Minutes After a Miscarriage Threat

WRITTEN BY: Tara Fernandez

Researchers have developed a chip-based test that can determine pregnancy outcomes after the signs of a possible miscarriage, such as pain and bleeding. By leveraging advances in nanotechnology, the assay provides answers in just half an hour. 

The first trimester is a trying time for pregnant mothers, with as many as one in five pregnancies facing miscarriage threats during this critical period. After presenting with symptoms, there is no easy way to determine if the pregnancy is at risk. Apart from invasive clinical procedures, there is also a serum progesterone test, which can take several hours to perform.

Scientists from Singapore’s Nanyang Technological University hypothesized that a technique called surface-enhanced Raman scattering (SERS) could hold the key. This is a surface-sensitive technique for detecting “ultratrace” amounts of biomarkers within complex biological samples such as blood or urine. The team created a diagnostic chip that is coated with a chemical called 4-mercaptophenylboronic acid, or MPBA. This acts as a chemical net, capturing these miscarriage-related biomarkers in the urine.

"Usually molecules associated with miscarriage risk are simply too dilute within the body's fluids and challenging to detect at low concentrations,” said study lead Ling Xing Yi. “To solve this problem, our group developed an innovative SERS 'confine and capture' approach and used a chemical 'targeting agent' to isolate miscarriage-related biomarkers from urine, resulting in speedy detection of miscarriage risk."

The team validated the new technology in a cohort of 40 pregnant women who sought medical help after experiencing the symptoms of threatened miscarriage. The test results lined up with pregnancy outcomes in all 40 patients. 

“This non-invasive toolkit will enable clinicians to predict the risk of a spontaneous miscarriage in women who presents with a threatened miscarriage,” said obstetrics and gynecology expert Ku Chee Wai, who also contributed to the study. 

“Early detection will also allow these pregnant women to receive counseling, medical interventions, or be under close medical management for adverse pregnancy outcomes throughout the rest of their pregnancy. It can also allay the fears and worries of pregnant women who are at low risk of miscarriage and improve their pregnancy experience.”

The team has patented the technology and is looking towards commercializing it and expanding its application scope to include diagnostics for other health conditions.

 

 

Source: ACS Nano, Nanyang Technological University.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
DEC 08, 2020
Genetics & Genomics
Advancing Genetic Sequencing with Better Computational Tools
DEC 08, 2020
Advancing Genetic Sequencing with Better Computational Tools
The many advances that have propelled the field of genetics forward have taken a tremendous amount of work in different ...
FEB 01, 2021
Genetics & Genomics
As Many as 20% of Patients Would Benefit From Pharmacogenetic Testing
FEB 01, 2021
As Many as 20% of Patients Would Benefit From Pharmacogenetic Testing
Researchers have suggested that a simple genetic test could be a huge benefit to public health; it could tell clinicians ...
FEB 15, 2021
Clinical & Molecular DX
Asking Patients the Right Questions About Their Symptoms
FEB 15, 2021
Asking Patients the Right Questions About Their Symptoms
A patient is admitted to the hospital after experiencing chest pains. What are the right questions that hospital staff a ...
MAR 16, 2021
Clinical & Molecular DX
A Blood Test for Predicting if You'll Live to 100
MAR 16, 2021
A Blood Test for Predicting if You'll Live to 100
In 2012, a United Nations report estimated that there are over 316,000 people worldwide over the age of 100. What’ ...
MAR 23, 2021
Cell & Molecular Biology
One Metabolic Problem May Cause Multiple Diseases
MAR 23, 2021
One Metabolic Problem May Cause Multiple Diseases
Patients with a disease often see specialists, and there may not be much communication among them when individuals suffe ...
APR 13, 2021
Clinical & Molecular DX
A Color-Changing "Invisible Tattoo" for Long-Term Health Monitoring
APR 13, 2021
A Color-Changing "Invisible Tattoo" for Long-Term Health Monitoring
German researchers have developed an innovative method for continuously tracking and monitoring biomarkers and drugs cir ...
Loading Comments...